Skip to main content
Caplight Logo









Ombre

Ombre

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.ombrelab.com/

Last Round

Seed

Nov 1, 2021

Total Funding Raised

$4.4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ombre is a health and wellness company that provides at-home gut microbiome testing kits, personalized food recommendations, and strain-specific probiotic subscriptions.

Sector

Healthcare & Life Sciences

Verticals

D2C Brands, Subscription Commerce, Biotechnology, E-commerce, Home & Lifestyle

Business Model

B2C

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

at-home microbiome testgut health testtargeted probioticsmicrobiome analysissupplement subscriptionpersonalized wellnessprebiotic supplementsDTC wellnessgut healthvaginal health testpersonalized microbiome report16S rRNA sequencingHSA/FSA eligible

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ombre Comparables

Compare Ombre with similar companies based on industry and business-model similarity.

Ombre comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Floré
87%
Viome Life Sciences, Inc.
84%
Tiny Health
82%

Ombre Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 1, 2021
SeedMay 15, 2018
SeedFeb 17, 2017

Key People

Founding team and executive leadership

Joe Starnes

Chief Executive Officer

Executive Team

Piotr Kuczynski

Chief Operating Officer

Executive Team

Ombre Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors increased 58% MoM.

  • Apr 22, 2026

    Monthly visitors increased 40% MoM, reaching 15.3K.

Ombre Filings

Explore SEC and related filing metadata, where available.

Ombre filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ombre's valuation, stock price, and market status.

Is Ombre a public or private company?

Ombre is a private company.

What is the current stock price of Ombre?

Ombre is a private company with no public stock price. No recent secondary market data is available.

How much is Ombre worth (valuation)?

Valuation information for Ombre is not publicly available.

Can I buy Ombre stock?

Ombre shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ombre's last funding round?

Ombre's most recent funding round was Seed on November 1, 2021.

Who are the main investors in Ombre?

Key investors in Ombre include PivotNorth Capital.

Will Ombre IPO soon?

No public IPO plans have been announced for Ombre.

How can I track Ombre secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ombre's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range22
Year Founded2016
Last FundingNov 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?